GSK provides update on Herpevac trial for women evaluating Simplirixâ„¢ (Herpes Simplex Vaccine)

GlaxoSmithKline (GSK) has made the decision not to pursue further worldwide development of Simplirixâ„¢ (Herpes Simplex Vaccine), an experimental vaccine intended to prevent genital herpes disease in women. (Source: GSK news)